Atlas FDA

COAPTITE Injectable Implant

FDA premarket approval P040047/S078 · decided 2025-08-27

Approval details

PMA number
P040047
Supplement
S078
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
COAPTITE Injectable Implant
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Merz North America, Inc.
Date received
2025-07-28
Decision date
2025-08-27
Days to decision
30 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Franksville, WI
Statement
two updates to the instructions for use of Coaptite

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29